Quarterly Report

Amphastar Pharmaceuticals, Inc. Filed 2015-08-13 Acc 0001171843-15-004674

Documents 1

2015-11-13 10-Q Quarterly Report
2015-08-19 4 CEO & Chief Scientific Officer acquired 16,962 shares (option exercise)
2015-08-19 4 Director sold 14,500 shares at an average $14.67 ($212,779)
2015-08-13 10-Q Quarterly Report
2015-08-12 8-K Results of operations
2015-05-14 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading gff10q_081315.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…